MedTrace Logo

Simvastatin Therapy in Women With Polycystic Ovary Syndrome.

NCT00365638 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-08-17

No results posted yet for this study

Summary

The purpose of this study is to determine whether statins (simvastatin) improve clinical (excessive hair, skin problems), endocrine (androgens) and metabolic (lipids, markers of systemic inflammation) in women with polycystic ovary syndrome (PCOS).

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

simvastatin

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Leszek Pawelczyk, MD PhD · Poznan University of Medical Sciences

  • Antoni J Duleba, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Completion
2005-02-28

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00365638 on ClinicalTrials.gov